Clinical trials
Completed Phase 3 trials in Guatemala
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
173 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 4 |
| 2003 | 9 |
| 2004 | 4 |
| 2005 | 6 |
| 2006 | 10 |
| 2007 | 2 |
| 2008 | 13 |
| 2009 | 13 |
| 2010 | 19 |
| 2011 | 12 |
| 2012 | 16 |
| 2013 | 9 |
| 2014 | 8 |
| 2015 | 7 |
| 2016 | 3 |
| 2017 | 7 |
| 2018 | 5 |
| 2019 | 7 |
| 2020 | 8 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 173 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 39 |
| Hoffmann-La Roche | 29 |
| Merck Sharp & Dohme LLC | 16 |
| Sanofi | 12 |
| Takeda | 11 |
| Boehringer Ingelheim | 10 |
| Novartis | 6 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 5 |
| NICHD Global Network for Women's and Children's Health | 4 |
| Pfizer | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 27 |
| Breast Neoplasms | 12 |
| Hypertension | 10 |
| Asthma | 9 |
| Diabetes Mellitus | 9 |
| Stomach Neoplasms | 9 |
| Arthritis, Rheumatoid | 8 |
| Glucose Metabolism Disorders | 8 |
| Pulmonary Disease, Chronic Obstructive | 8 |
| Dyslipidemias | 7 |
Trials
Showing 1 to 25 of 173. Each trial links to its page on Pharma Observatory.
73 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.